5-[5-[(1-acetylpiperidin-3-yl)methoxy]-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one
C21H26F4N4O3 — CID 154825715
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[5-[(1-acetylpiperidin-3-yl)methoxy]-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one
5-[5-[(1-acetylpiperidin-3-yl)methoxy]-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one (PubChem CID 154825715) has the molecular formula C21H26F4N4O3 and a molecular weight of 458.46 g/mol. Its IUPAC name is 5-[5-[(1-acetylpiperidin-3-yl)methoxy]-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one.
Molecular Properties
| Compound Name | 5-[5-[(1-acetylpiperidin-3-yl)methoxy]-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one |
|---|---|
| PubChem CID | 154825715 |
| Molecular Formula | C21H26F4N4O3 |
| Molecular Weight | 458.46 g/mol |
| Exact Mass | 458.19 |
| IUPAC Name | 5-[5-[(1-acetylpiperidin-3-yl)methoxy]-6-fluoro-1,3-dihydroisoindol-2-yl]-4-(trifluoromethyl)diazinan-3-one |
| SMILES | CC(=O)N1CCCC(COc2cc3c(cc2F)CN(C2CNNC(=O)C2C(F)(F)F)C3)C1 |
| InChI | InChI=1S/C21H26F4N4O3/c1-12(30)28-4-2-3-13(8-28)11-32-18-6-15-10-29(9-14(15)5-16(18)22)17-7-26-27-20(31)19(17)21(23,24)25/h5-6,13,17,19,26H,2-4,7-11H2,1H3,(H,27,31) |
| InChIKey | KMHRURNIAZKGBQ-UHFFFAOYSA-N |
| XLogP | 1.96 |
| TPSA | 73.91 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 458.46 |
| LogP ≤ 5 | 1.96 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154825715 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.